John A. Ward

Array ( [id] => 7024866 [patent_doc_number] => 20050019260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Animal model for allergy' [patent_app_type] => utility [patent_app_number] => 10/479600 [patent_app_country] => US [patent_app_date] => 2002-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12325 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019260.pdf [firstpage_image] =>[orig_patent_app_number] => 10479600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701082 [patent_doc_number] => 20030223962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Delivery of gene products to the lung parenchyma via gene transfer to the pleura' [patent_app_type] => new [patent_app_number] => 10/161356 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6559 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20030223962.pdf [firstpage_image] =>[orig_patent_app_number] => 10161356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6654128 [patent_doc_number] => 20030077274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1' [patent_app_type] => new [patent_app_number] => 10/162396 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15185 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077274.pdf [firstpage_image] =>[orig_patent_app_number] => 10162396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6720306 [patent_doc_number] => 20030053994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Redirection of cellular immunity by protein tyrosine kinase chimeras' [patent_app_type] => new [patent_app_number] => 10/151193 [patent_app_country] => US [patent_app_date] => 2002-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17672 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20030053994.pdf [firstpage_image] =>[orig_patent_app_number] => 10151193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846720 [patent_doc_number] => 20030165887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Methods for determining the prognosis for cancer patients using tucan' [patent_app_type] => new [patent_app_number] => 10/141618 [patent_app_country] => US [patent_app_date] => 2002-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23624 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165887.pdf [firstpage_image] =>[orig_patent_app_number] => 10141618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797504 [patent_doc_number] => 20030176378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Vaccines and gene therapy compositions and methods of making and using the same' [patent_app_type] => new [patent_app_number] => 10/139423 [patent_app_country] => US [patent_app_date] => 2002-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18862 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176378.pdf [firstpage_image] =>[orig_patent_app_number] => 10139423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6724574 [patent_doc_number] => 20030206886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Neutralization of immune suppressive factors for the immunotherapy of cancer' [patent_app_type] => new [patent_app_number] => 10/138783 [patent_app_country] => US [patent_app_date] => 2002-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9606 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20030206886.pdf [firstpage_image] =>[orig_patent_app_number] => 10138783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 539167 [patent_doc_number] => 07166278 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-23 [patent_title] => 'Modified organs and cells for xenotransplantation' [patent_app_type] => utility [patent_app_number] => 10/135919 [patent_app_country] => US [patent_app_date] => 2002-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 10461 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/166/07166278.pdf [firstpage_image] =>[orig_patent_app_number] => 10135919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6817350 [patent_doc_number] => 20030068308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Intrasplenic encapsulated cell therapy' [patent_app_type] => new [patent_app_number] => 10/132443 [patent_app_country] => US [patent_app_date] => 2002-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4302 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068308.pdf [firstpage_image] =>[orig_patent_app_number] => 10132443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6260270 [patent_doc_number] => 20020187543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Enhanced dispersion of adenoviral vectors by fusogenic membrane glycoproteins' [patent_app_type] => new [patent_app_number] => 10/117488 [patent_app_country] => US [patent_app_date] => 2002-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7365 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187543.pdf [firstpage_image] =>[orig_patent_app_number] => 10117488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6682724 [patent_doc_number] => 20030118588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Induction of anti-tumor CTL immunity through in vivo triggering of 4-1BB and/or CD40' [patent_app_type] => new [patent_app_number] => 10/115620 [patent_app_country] => US [patent_app_date] => 2002-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 11018 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20030118588.pdf [firstpage_image] =>[orig_patent_app_number] => 10115620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6156699 [patent_doc_number] => 20020146398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Tissue growth stimulating system' [patent_app_type] => new [patent_app_number] => 10/114438 [patent_app_country] => US [patent_app_date] => 2002-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 960 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146398.pdf [firstpage_image] =>[orig_patent_app_number] => 10114438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174421 [patent_doc_number] => 20020155104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Regulation of T cell-mediated immunity by tryptophan' [patent_app_type] => new [patent_app_number] => 10/112362 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15230 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155104.pdf [firstpage_image] =>[orig_patent_app_number] => 10112362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6749878 [patent_doc_number] => 20030044398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Methods for producing antibodies in mammals' [patent_app_type] => new [patent_app_number] => 10/095875 [patent_app_country] => US [patent_app_date] => 2002-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13412 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044398.pdf [firstpage_image] =>[orig_patent_app_number] => 10095875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5905018 [patent_doc_number] => 20020141983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease' [patent_app_type] => new [patent_app_number] => 10/098035 [patent_app_country] => US [patent_app_date] => 2002-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7547 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20020141983.pdf [firstpage_image] =>[orig_patent_app_number] => 10098035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 83309 [patent_doc_number] => 07741116 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Surgical device for skin therapy or testing' [patent_app_type] => utility [patent_app_number] => 10/092237 [patent_app_country] => US [patent_app_date] => 2002-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5967 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741116.pdf [firstpage_image] =>[orig_patent_app_number] => 10092237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6158891 [patent_doc_number] => 20020147172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors' [patent_app_type] => new [patent_app_number] => 10/092454 [patent_app_country] => US [patent_app_date] => 2002-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12792 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147172.pdf [firstpage_image] =>[orig_patent_app_number] => 10092454 [rel_patent_id] =>[rel_patent_doc_number] =>)